# Prevention of New Onset AF After TAVI (PAF-TAVI Trial)

> **NCT03991754** · PHASE3 · UNKNOWN · sponsor: **Luis Nombela Franco** · enrollment: 120 (estimated)

## Conditions studied

- Atrial Fibrillation New Onset

## Interventions

- **PROCEDURE:** transcatheter aortic valve implantation

## Key facts

- **NCT ID:** NCT03991754
- **Lead sponsor:** Luis Nombela Franco
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-06-30
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2019-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03991754

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03991754, "Prevention of New Onset AF After TAVI (PAF-TAVI Trial)". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03991754. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*